Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease

Vaccine

Volumn 26, Issue SUPPL.6, 2008, Pages

  Lu, Zengjun ^a   Bao, Huifang ^a   Cao, Yimei ^a   Sun, Pu ^a   Guo, Jianhun ^a   Li, Pinghua ^a   Bai, Xingwen ^a   Chen, Yingli ^a   Xie, Baoxia ^a   Li, Dong ^a   Liu, Zaixin ^a   Xie, Qingge ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Adenovirus; Foot and mouth disease virus; Swine; Vaccine

Indexed keywords

3C PROTEASES; CYSTEINE PROTEINASE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ADENOVIRUS; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CLASSIFICATION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENETICS; GUINEA PIG; IMMUNOLOGY; METABOLISM; SEROTYPING; SWINE; SWINE DISEASE; VACCINATION; VIROLOGY; VIRUS CAPSID;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CAPSID; CYSTEINE ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GUINEA PIGS; RECOMBINANT PROTEINS; SEROTYPING; SWINE; SWINE DISEASES; VACCINATION; VIRAL PROTEINS; VIRAL VACCINES;

EID: 62849083315     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.09.066     Document Type: Article

References (33)

1. Sevilla N, Domingo E. Evolution of a persistent aphthovirus in cytolytic infections: partial reversion of phenotypic traits accompanied by genetic diversification. J Virol 1996;70:6617-24.
2. Araujo Jr JP, Montassier HJ, Pinto AA. Extensive antigenic and genetic variation among foot-and-mouth disease type A viruses isolated from the 1994 and 1995 foci in Sao Paulo. Braz Vet Microbiol 2002;84:15-27.
3. Dunn CS, Donaldson AI. Natural adaption to pigs of a Taiwanese isolate of footand-mouth disease virus. Vet Rec 1997;141:174-5.
4. Davies G. The foot and mouth disease (FMD) epidemic in the United Kingdom 2001. Comp Immunol, Microbiol Infect Dis 2002;25:331-43.
5. Beck E, Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol 1987;61:1621-9.
6. Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, et al. Foot-and-mouth virus: a long known virus, but a current threat. Vet Res 2001;32:1-30.
7. Bolwell C, Brown AL, Barnett PV, Campbell RO, Clarke BE, Parry NR, et al. Host cell selection of antigenic variants of foot-and-mouth disease virus. J Gen Virol 1989;70:45-57.
8. Roosien J, Belsham GJ, Ryan MD, King AMQ, Vlak JM. Synthesis of foot-andmouth disease virus capsid protein in insect cells using baculovirus expression vector. J Gen Virol 1990;71:1703-11.
9. Wigdorovitz A, Carrillo C, Dus Santos MJ, Sadir AM, Rios R, Franzione P, et al. Induction of a protective antibody response to foot-and-mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 1999;255(2):347-53.
10. Chan EWC, Wong HT, Cheng SC, Yan WY, Zheng ZX, Sheng ZT, et al. An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine. Vaccine 2001;19(4-5):538-46.
11. Wang CY, Chang TY, Walfield AM, Ye J, Shen M, Chen SP, et al. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 2002;20:2603-10.
12. McKenna Thomas SC, Lubroth J, Rieder E, Baxt B, Mason PW. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J Virol 1995;69(9):5787-90.
13. Mason PW, Piccone ME, McKenna ST-C, Chinsangaram J, Grubman MJ. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology 1997;227:96-102.
14. Ward G, Rieder E, Mason PW. Plasmid DNA encoding replicating foot-andmouth disease virus genomes induces antiviral immune response in swine. J Virol 1997;71:7442-7.
15. Cedillo-Barron L, Foster-Cuevas M, Belsham GJ, Lefevre F, Parkhouse RM. Induction of a protective response in swine vaccinated withDNAencoding footand-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J Gen Virol 2001;82:1713-24.
16. Kit S, Kit M, DiMarchi RD, Little SP, Gale C. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimmer forms of footand-mouth disease capsid protein epitopes on surface of hybrid virus particles. Arch Virol 1991;120:1-17.
17. Qian P, Li XM, Jin ML, Peng GQ, Chen HC. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Vaccine 2004;22(17-18):2129-36.
18. Mayr GA, Chinsangaram T, Grubman M. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding region of foot-and-mouth disease virus as a vaccine candidate. Virology 1999;263:496-506.
19. Moraes MP,Mayr GA, Mason PW, Grubman MJ. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002;20:1631-9.
20. Zhang XS, Liu ZX, Zhao QZ, Chang HY, Xie QG. Sequencing and analysis for the full-length genome RNA of foot-and-mouth disease virus China/99. Sci China Ser C Life Sci 2004;47:174-81.
21. Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003;91:65-80.
22. Spector DL, Goldman RD, Leinwand LA, editors. Cells; A Laboratory Manual. Cold Spring Harbor Laboratory Press; 1998.
23. OIE (Office International des Epizooties), Foot-and-mouth disease. In: OIE Standards Commission, editor.Manual of standards for diagnostic tests and vaccines. 5th ed. Paris, France: Office International des Epizooties, 2005 [Chapter 2.1.1].
24. Jimenez-Clavero MA, Escribano-Romero E, Sanchez-Vizcaino JM, Ley V. Molecular cloning, expression and immunological analysis of the capsid precursor polypeptide (P1) from swine vesicular disease virus. Virus Res 1998;57: 163-70.
25. Hamblin C, Barnett ITR, Crowther JR. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods 1986;93:115-21.
26. Hamblin C, Barnett ITR, Crowther JR. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Appl J Immunol Methods 1986;93:123-9.
27. Terpstra C, Frenkel S, Straver PJ, Barteling SJ, van Bekkum JG. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-andmouth disease virus cultures and vaccines. In: International Symposium on Foot-and-Mouth Disease (II), Lyon 1976. Develop Boil Standard, vol. 35. 1977. p. 333-42.
28. Lu Z, Cao Y, Guo J, Qi S, Li D, Zhang Q, et al. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Vet Microbiol 2007;125:157-69.
29. Doel TR. FMD vaccines. Virus Res 2003;91:81-91.
30. Sanz-Parra A, Jimenez-Clavero MA, Garcia-Briones MM, Blanco E, Sobrino F, Ley V. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor ploypeptide P1 induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (New York) 1999;259(1):129-34.
31. Becker Y. Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)-a point of view. Virus Genes 1994;8:199-214.
32. Collen T, Pullen L, Doel TR. T cell dependent induction of antibody against footand-mouth disease virus in a mouse model. Virology 1989;70:395-403.
33. Wu QH, Moraes MP, Grubman MJ. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine. Virus Res 2003;93:211-9.